Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Change in Account Payables (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Change in Account Payables for 2 consecutive years, with $1.1 million as the latest value for Q4 2023.

  • On a quarterly basis, Change in Account Payables rose 200.65% to $1.1 million in Q4 2023 year-over-year; TTM through Dec 2023 was $856000.0, a 341.24% increase, with the full-year FY2024 number at -$4.3 million, down 599.88% from a year prior.
  • Change in Account Payables was $1.1 million for Q4 2023 at LENZ Therapeutics, down from $2.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.0 million in Q3 2023 to a low of -$1.6 million in Q2 2023.